In this study, SERPINA3 was identified to be a direct target gene of ERα, and its downregulation enhanced the expression of ankyrin repeat domain containing 11 (ANKRD11), which resulted in elevated HDAC3 activity and AI resistance in ER+ breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.